US Patent Issued to PROGEN on Feb. 10 for "Modified immunoglobulin Fc-fusion protein and use thereof" (South Korean Inventors)

ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,545,713, issued on Feb. 10, was assigned to PROGEN Co. LTD. (Seoul, South Korea).

"Modified immunoglobulin Fc-fusion protein and use thereof" was invented by Hyun-Tak Jin (Seongnam-si, South Korea), Eun Joo Nam (Seoul, South Korea) and Je-In Youn (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a novel immunoglobulin Fc domain variant protein and use thereof, and when expressed in the form of a fusion protein with another biologically active protein, an immunoglobulin Fc domain variant protein according to an embodiment of the present invention can prolong the half-life in vivo of the biologically activ...